Journal: Cell reports
Article Title: Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis
doi: 10.1016/j.celrep.2021.110146
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet: The following primary antibodies were used at 1:200 dilution: PAX8 (Proteintech, 21384–1-AP), TUBB4A (Abcam, ab1315), POU5F1 (Stemgent, 09–0023), Nanog (Stemgent, 09–0020), SOX2 (Stemgent, 09–0024), TRA-1–60 (Stemgent, 09–0010), TRA-1–81 (Stemgent, 09–0011), SSEA4 (Stemgent, 09–0006), CDH1 (R&D System, AF648), OVGP1 (SIGMA, HPA062205), p53 (DO-1) (Santa Cruz Biotechnology, sc-126), Ki-67 (SP6) (Invitrogen, MA5–14520) MUC-16 (Sigma, HPA065600).
Techniques: Recombinant, Plasmid Preparation, Avidin-Biotin Assay, Lactate Dehydrogenase Assay, CyQUANT Assay, Prestoblue Assay, Bradford Assay, Blocking Assay, RNA Sequencing Assay, Mutagenesis, Real-time Polymerase Chain Reaction, Software